GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005122234 | Thyroid | ATC | positive regulation of protein transport | 165/6293 | 303/18723 | 4.94e-14 | 2.69e-12 | 165 |
GO:007058533 | Thyroid | ATC | protein localization to mitochondrion | 83/6293 | 125/18723 | 6.24e-14 | 3.37e-12 | 83 |
GO:007265533 | Thyroid | ATC | establishment of protein localization to mitochondrion | 80/6293 | 120/18723 | 1.27e-13 | 6.46e-12 | 80 |
GO:000662626 | Thyroid | ATC | protein targeting to mitochondrion | 67/6293 | 100/18723 | 8.62e-12 | 3.21e-10 | 67 |
GO:000726524 | Thyroid | ATC | Ras protein signal transduction | 172/6293 | 337/18723 | 2.25e-11 | 7.96e-10 | 172 |
GO:000836026 | Thyroid | ATC | regulation of cell shape | 91/6293 | 154/18723 | 7.33e-11 | 2.31e-09 | 91 |
GO:190321422 | Thyroid | ATC | regulation of protein targeting to mitochondrion | 33/6293 | 44/18723 | 2.29e-08 | 4.44e-07 | 33 |
GO:190374722 | Thyroid | ATC | regulation of establishment of protein localization to mitochondrion | 36/6293 | 50/18723 | 3.21e-08 | 6.00e-07 | 36 |
GO:190353316 | Thyroid | ATC | regulation of protein targeting | 51/6293 | 81/18723 | 6.02e-08 | 1.07e-06 | 51 |
GO:005105618 | Thyroid | ATC | regulation of small GTPase mediated signal transduction | 141/6293 | 302/18723 | 1.43e-06 | 1.77e-05 | 141 |
GO:000726619 | Thyroid | ATC | Rho protein signal transduction | 73/6293 | 137/18723 | 1.58e-06 | 1.93e-05 | 73 |
GO:190395513 | Thyroid | ATC | positive regulation of protein targeting to mitochondrion | 24/6293 | 32/18723 | 1.99e-06 | 2.39e-05 | 24 |
GO:190374916 | Thyroid | ATC | positive regulation of establishment of protein localization to mitochondrion | 26/6293 | 36/18723 | 2.47e-06 | 2.90e-05 | 26 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RHOU | insertion | Nonsense_Mutation | novel | c.772_773insCTGAAGTCAGACCCTGAGGATAAGATGGAAGTCAGGAAAA | p.Val258AlafsTer6 | p.V258Afs*6 | Q7L0Q8 | protein_coding | | | TCGA-B6-A0IK-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
RHOU | SNV | Missense_Mutation | | c.229N>A | p.Glu77Lys | p.E77K | Q7L0Q8 | protein_coding | tolerated(0.08) | benign(0.038) | TCGA-C5-A1BK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
RHOU | SNV | Missense_Mutation | rs780664653 | c.395N>A | p.Ser132Asn | p.S132N | Q7L0Q8 | protein_coding | tolerated(0.31) | benign(0.018) | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RHOU | SNV | Missense_Mutation | rs764760417 | c.661G>A | p.Ala221Thr | p.A221T | Q7L0Q8 | protein_coding | deleterious(0.05) | benign(0.352) | TCGA-AD-6965-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | PD |
RHOU | SNV | Missense_Mutation | novel | c.505N>A | p.Val169Ile | p.V169I | Q7L0Q8 | protein_coding | deleterious(0.04) | benign(0.162) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RHOU | SNV | Missense_Mutation | novel | c.530N>C | p.Lys177Thr | p.K177T | Q7L0Q8 | protein_coding | deleterious(0.01) | possibly_damaging(0.458) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
RHOU | SNV | Missense_Mutation | | c.289N>A | p.Val97Met | p.V97M | Q7L0Q8 | protein_coding | deleterious(0.01) | possibly_damaging(0.848) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RHOU | SNV | Missense_Mutation | | c.617N>C | p.Leu206Ser | p.L206S | Q7L0Q8 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AX-A063-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RHOU | SNV | Missense_Mutation | rs776181808 | c.658N>A | p.Val220Ile | p.V220I | Q7L0Q8 | protein_coding | tolerated(0.08) | benign(0.009) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
RHOU | SNV | Missense_Mutation | novel | c.343N>T | p.Pro115Ser | p.P115S | Q7L0Q8 | protein_coding | tolerated(0.18) | benign(0.289) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |